On Invalid Date, Avenue Therapeutics (NASDAQ: ATXI) reported Q4 2023 earnings per share (EPS) of $0.56, up 54.47% year over year. Total Avenue Therapeutics earnings for the quarter were $640.00 thousand. In the same quarter last year, Avenue Therapeutics's earnings per share (EPS) was $1.23.
As of Q1 2024, Avenue Therapeutics's earnings has grown year over year. Avenue Therapeutics's earnings in the past year totalled -$10.38 million.
What is ATXI's earnings date?
Avenue Therapeutics's earnings date is Invalid Date. Add ATXI to your watchlist to be reminded of ATXI's next earnings announcement.
What was ATXI's revenue last quarter?
On Invalid Date, Avenue Therapeutics (NASDAQ: ATXI) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Avenue Therapeutics's revenue was $0.00.
What was ATXI's revenue growth in the past year?
As of Q1 2024, Avenue Therapeutics's revenue has grown null year over year. Avenue Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.